Las Vegas, NV -- (SBWIRE) -- 10/31/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: RPX Corp (NASDAQ:RPXC), Magnachip Semiconductor Corp (NYSE:MX), Cousins Properties Inc (NYSE:CUZ), Halozyme Therapeutics, Inc. (NASDAQ:HALO)
RPX Corp (NASDAQ:RPXC) managed to keep its gain at 5.48% on above-normal volume of 1.56M shares. The stock settled at $18.29 after floating in a range of $17.89 to $18.75. Its latest price has reached market capitalization of $963.95 million. Its 52-week range has been $8.55 to $19.88. RPX Corporation (RPX) provides patent risk management solutions, offering defensive buying, acquisition syndication, patent intelligence and advisory services.
For How Long RPXC will fight for Profitability? Read This Trend Analysis report
Magnachip Semiconductor Corp (NYSE:MX) traded down on a volume of 1.56 million, higher than its standard daily volume. Shares have dropped-8.73% to $19.13. Over the last twelve months, the stock has gained 69.59% and faced a worst price of $10.85. MagnaChip Semiconductor Corporation (MagnaChip Semiconductor) is a designer and manufacturer of analog and mixed-signal semiconductor products for consumer applications.
Has MX Found The Bottom And Ready To Gain Momentum? Find Out Here
Cousins Properties Inc (NYSE:CUZ) settled -0.72% lower at $11.02 on below -normal volume of 1.55M shares during the last trading day. The stock has its 12-month high at $11.42 and 52-week low price was $7.67. It traded in a range of $11.01 to $11.12 during the last trading day. Cousins Properties Incorporated (Cousins) is a real estate investment trust (REIT). Cousins Real Estate Corporation and its subsidiaries (CERC) are wholly owned by the Company. CERC owns, develops, and manages its own real estate portfolio and performs certain real estate related services for other parties.
Will CUZ Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Halozyme Therapeutics, Inc. (NASDAQ:HALO) was down on low volume, trading at a volume of 1.54M shares versus its average daily volume of 2.05 million shares. At $11.40, the stock has attained market capitalization of $1.29 billion. Halozyme Therapeutics, Inc. is a biopharmaceutical company. The Company’s research focuses primarily on human enzymes that alter the extracellular matrix. The Company’s pipeline consists of multiple clinical stage products in diabetes, oncology and dermatology.
Why Should Investors Buy HALO After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)